B-ALL の子供の卵巣再発:症例報告
Meriem Cheikhna1, Chaimae El Mahdaoui2, Nisrine Bennani Guebessi2,3
1Hematology and Pediatric Oncology Department of August 20 Hospital, Ibn Rochd University Hospital, Casablanca, Morocco.
The Pan African medical journal
|August 27, 2025
まとめ
B細胞急性リンパ性白血病 (B-ALL) を患った8歳の少女は,希少な卵巣再発を経験しました. これは,小児ALL患者の寛解後の注意深いフォローアップとイメージングの必要性を強調しています.
科学分野:
- 小児腫瘍学
- 血液学
- 遺伝学
背景:
- B 細胞急性リンパ性白血病 (B-ALL) は,子供期の一般的な癌です.
- ETV6-RUNX1に関連した染色体12の削除のような好ましい遺伝的マーカーは,遅い再発のリスクを伴う可能性があります.
- 乳腺外再発,特に卵巣での再発は,小児性B-ALLでは非常にまれである.
関連する概念動画
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:22Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495